NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Monday that its second quarter revenues rose 9 percent year over year, thanks to growth across all of its business units.

For the three months ended April 30, the life sciences company said total revenues rose to $1.21 billion from $1.10 billion in Q2 2017, in line with analysts' average estimate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.